Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.050
+0.090 (4.59%)
At close: Jul 30, 2025, 4:00 PM
2.070
+0.020 (0.98%)
After-hours: Jul 30, 2025, 7:04 PM EDT
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts that cover Caribou Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $8.5, which forecasts a 314.63% increase in the stock price over the next year. The lowest target is $3 and the highest is $14.
Price Target: $8.5 (+314.63%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 28, 2025.
Analyst Ratings
The average analyst rating for Caribou Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +46.34% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +339.02% | Mar 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +436.59% | Jan 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $6 | Strong Buy | Maintains | $30 → $6 | +192.68% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +339.02% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
10.95M
from 9.99M
Increased by 9.52%
Revenue Next Year
10.60M
from 10.95M
Decreased by -3.19%
EPS This Year
-1.46
from -1.65
EPS Next Year
-1.19
from -1.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.7M | 12.1M | 15.8M | ||
| Avg | 10.9M | 10.6M | 12.2M | ||
| Low | 9.7M | 9.7M | 9.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1% | 10.3% | 48.6% | ||
| Avg | 9.5% | -3.2% | 15.0% | ||
| Low | -2.5% | -11.0% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.86 | -0.53 | 0.03 | ||
| Avg | -1.46 | -1.19 | -1.01 | ||
| Low | -1.85 | -1.68 | -1.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.